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The catalytic activity of the Src family of tyrosine ki-
nases is suppressedbyphosphorylationona tyrosine
residue located near the C terminus (Tyr 527 in c-Src),
which is catalyzed by C-terminal Src Kinase (Csk).
Given the promiscuity of most tyrosine kinases, it is
remarkable that the C-terminal tails of the Src family
kinases are the only known targets of Csk. We have
determined the crystal structure of a complex be-
tween the kinase domains of Csk and c-Src at 2.9 A˚
resolution, revealing that interactions between these
kinases position the C-terminal tail of c-Src at the
edge of the active site of Csk. Csk cannot phosphor-
ylate substrates that lack this docking mechanism
because the conventional substrate binding site
used by most tyrosine kinases to recognize sub-
strates is destabilized in Csk by a deletion in the acti-
vation loop.
INTRODUCTION
Protein tyrosine kinases are key components of the signaling
networks that regulate growth and proliferation in metazoans
(Manning et al., 2002). Although kinase activity is tightly regu-
lated by various mechanisms, these mechanisms converge on
a conserved element in the active site of the kinase domain
called the activation loop. The conformation of the activation
loop is responsive to phosphorylation (Huse and Kuriyan,
2002), which stabilizes the active configuration of catalytic resi-
dues in most kinases and also promotes the binding of peptide
substrates (Nolen et al., 2004).
The catalytic domains of most tyrosine kinases are highly pro-
miscuous (Miller, 2003), and specificity is achieved by controlling
the localization and activity of the kinase. This is exemplified by
the observation that deregulation and overexpression of tyrosine
kinases result in the phosphorylation of a large and heteroge-
neous set of proteins (Superti-Furga et al., 1993; Takashima
et al., 2003; Walkenhorst et al., 1996).
C-terminal Src Kinase (Csk) is unusual among tyrosine kinases
because it readily phosphorylates only one class of substrate,124 Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc.a conserved tyrosine in the C-terminal tails of the Src family
kinases (Tyr 527 in chicken c-Src [Takeya and Hanafusa,
1983]). This degree of specificity is retained even when Csk is
highly overexpressed (Superti-Furga et al., 1993). Phosphoryla-
tion byCsk stabilizes an inactive form of the Src kinases, in which
the phosphorylated tail binds to the Src homology 2 (SH2) do-
main (Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997,
1999). Csk (like its close relative Chk) is not regulated by activa-
tion loop phosphorylation and is instead active constitutively
(Brown and Cooper, 1996), a property that is consistent with
the need for Csk to inhibit the Src kinases continually (Okada
et al., 1991).
Like the Src kinases, Csk possesses a Src-homology 3 (SH3)
domain and an SH2 domain. The SH2 domain binds to the phos-
phorylated substrates of Src kinases, thereby targeting Csk to
sites of Src kinase activity (Bergman et al., 1995; Howell and
Cooper, 1994; Neet and Hunter, 1995; Sabe et al., 1994). These
targetingmechanisms are not critical for the specificity of Csk for
the Src kinases, which is apparent in vitro. Indeed, Csk displays
extremely poor activity toward tyrosine-containing peptides,
with the best peptides selected from a peptide library displaying
KM values in the millimolar range (Sondhi et al., 1998). By
comparison, the tyrosine kinases c-Src and c-Abl phosphorylate
their optimal peptide substrates with KM values in the range of
5–50 mM (Songyang et al., 1995). Unlike peptide substrates,
constructs of c-Src that include the folded kinase domain are
efficient substrates for Csk, with KM values of 5 mM (Sondhi
et al., 1998).
Here, we address two major questions regarding the specific-
ity of Csk for the Src kinases. First, while mutagenesis experi-
ments with Csk and c-Src have identified some of the residues
involved in the interaction between the two proteins (Lee et al.,
2003, 2006), no definitive description of the nature of the com-
plex is as yet available. Second, while the catalytic mechanism,
dynamics, and roles of the SH3 and SH2 domains of Csk have
been investigated extensively (Lieser et al., 2005, 2006; Wong
et al., 2004, 2005), these studies have not clarified why the Src
kinases are the only significant substrates of Csk. To address
the first question, we have determined the crystal structure of
a complex between the kinase domains of Csk and c-Src. This
structure shows that Csk recognizes the C-terminal lobe of the
c-Src kinase domain in a manner that positions the c-Src tail ad-
jacent to the active site of Csk. To address the second question,
we present a comparative analysis of the active sites of tyrosine
kinases that shows that the canonical binding site for substrates
is destabilized in Csk. As a consequence, Csk is efficient at
phosphorylating only the Src kinases, because they present
the phosphoacceptor tyrosine directly to the active site.
RESULTS AND DISCUSSION
Binding of Csk to c-Src and Crystallization
of the Complex
The kinase domain of Csk is sufficient to recognize c-Src protein
(Sondhi and Cole, 1999; Sun and Budde, 1999), but the dissoci-
ation constant (KD) for the Csk:c-Src interaction has not been
measured directly. We used surface plasmon resonance tomea-
sure the binding of Csk to c-Src. Constructs of c-Src were immo-
bilized on the sensor surface, and the binding of different con-
structs of Csk to the surface was monitored as a function of
Csk concentration (see Figure 1A for constructs and Figure 1B
for typical binding data). The affinity of Csk for c-Src is modest
and highly salt dependent (Figure 1C and Figure S1 available on-
line). Constructs of Csk that include the SH2 domain (full-length
Csk, CskFL, and a construct lacking the SH3 domain, CskSH2KD)
bind the kinase domain of c-Src (c-SrcKD) with KD values of 30
mM at 150 mM NaCl and 4 mM at 50 mM NaCl (Figures 1C and
S1B). The KD value for the kinase domain of Csk (CskKD) binding
to c-SrcKD is 70 mM at 150 mMNaCl (Figure 1C). When the salt
dependence of the affinity is considered, these values are in
agreement with reports that the Michaelis constant (KM) for
Figure 1. Binding of Csk to c-Src Measured
by Surface Plasmon Resonance
(A) Constructs of Csk and c-Src used in this paper.
(B) Representative data from the surface plasmon
resonance experiments. The sensorgrams ob-
tained with different concentrations of CskKD are
shown on the left. The equilibrium response at
each concentration was fitted to a single-site
binding model, shown on the right, to derive the
equilibrium dissociation constant.
(C) Equilibrium dissociation constants for several
different constructs of Csk and c-Src at 150 mM
NaCl. Values shown are the mean and standard
deviation from at least two separate titrations.
phosphorylation of c-Src by Csk is5 mM
(Lieser et al., 2005; Wang et al., 2001).
Because of the relatively low affinity of
Csk for c-Src, we were unable to purify
complexes of the two proteins. We
were, therefore, surprised to find that
CskKD and CskSH2KD both crystallized
readily in complex with c-SrcKD when
mixed together. It appears that the
adventitious formation of a disulfide
crosslink between Cys 290 in Csk and
Cys 277 in c-Src prevented the otherwise
facile crystallization of either protein sep-
arately. The disulfide bond links a Csk
molecule from one enzyme-substrate complex to a c-Src mole-
cule from a different complex (Figure S2A). The disulfide linkage
does not appear to influence the interaction between Csk and
c-Src within the biologically relevant Csk:c-Src complexes, as
the interface between Csk and c-Src is essentially identical in
two different crystal forms (see below), despite the fact that the
disulfide-linked molecules are rotated relative to each other in
the two structures (Figure S2B).
Crystals of either CskKD or CskSH2KD in complex with c-SrcKD
diffracted X-rays weakly. We mutated charged residues at the
surface of Csk in an effort to improve crystal quality (Derewenda,
2004), and two such mutations (Lys 361 Ala and Lys 362 Ala) im-
proved diffraction from the CskKD:c-SrcKD crystals. While these
mutations are known to decrease the activity of Csk (Lin et al.,
2005), they are distant from the Csk:c-Src interface (the Ca
atom of Lys 361 of Csk is more than 20 A˚ from the nearest Ca
atom in c-Src) and are, therefore, unlikely to influence the man-
ner in which c-Src binds to Csk. The CskKD:c-SrcKD crystals
were originally obtained in the presence of the ATP analog
AMP-PNP, but the use of the nonspecific kinase inhibitor stau-
rosporine further improved diffraction, allowing data to 2.9 A˚ to
be measured. Staurosporine is bound to both c-Src and Csk in
our structure. Structures of Csk and the Src family kinases Lck
and Fyn have been determined previously in the presence of
staurosporine (Kinoshita et al., 2006; Lamers et al., 1999; Zhu
et al., 1999).
We have also measured X-ray data to 4.1 A˚ for the CskSH2KD:
c-SrcKD crystals obtained in the presence of AMP-PNP. The SH2Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc. 125
domain of Csk is disordered in these crystals, but the kinase
domains of both Csk and c-Src are positioned reliably. Although
the lower resolution of this data set provides limited information,
it confirms the mode of interaction between the kinase domains
of c-Src and Csk and, in one of the molecules in the asymmetric
unit, allows visualization of the c-Src tail entering the Csk active
site. The discussion that follows is based on the higher-resolu-
tion CskKD:c-SrcKD structure unless otherwise noted.
The Csk:c-Src Interface
The interaction between c-Src and Csk is restricted to the C-ter-
minal lobes (C lobes) of the two kinase domains and buries
1200 A˚2 of surface area between the proteins (Figure 2A).
The interaction surface on c-Src is formedby theC-terminala he-
lices I and I0 (residues 508–524; see Figure 2 for the helix nota-
tion) and the loop that precedes them (residues 504–507, part
of the aH/aI loop; Figure 2B). This surface docks onto the side
of the C lobe of Csk, undergoing little adjustment in structure
when compared to structures of the isolated kinase domain of
c-Src (Breitenlechner et al., 2005; Seeliger et al., 2007). The inter-
action surface on c-Src is highly conserved among the Src family
members (Figure S3). The catalytically important Asp-Phe-Gly
(DFG) motif of c-Src adopts an inactive conformation in this
structure, but the surface of c-Src that binds to Csk is distant
from the active site, and the inactive conformation of the c-Src
kinase domain is unlikely to be induced by the binding of Csk.
The Csk:c-Src interface is largely electrostatic, consistent with
the salt-sensitive nature of the interaction: 5 arginine residues in
Figure 2. Structure of the Complex between the
Kinase Domains of Csk and c-Src
(A) The kinase domains of c-Src and Csk are depicted in their
relative orientations in the structure but separated so that the
Csk:c-Src interface, highlighted as dots, is visible. The Csk:
c-Src complex is oriented such that the kinase domain of
Csk is shown in the standard view (active site facing the
viewer). The orientation of the kinase domain of c-Src in the
complex is related to the standard view (on the left) by a rota-
tion of 90 about the vertical axis and 120 about an axis
perpendicular to the page.
(B) Overview of the CskKD:c-SrcKD complex. The approximate
path of the activation loop, which is disordered between resi-
dues 335 and 349, is indicated by a dotted red line. The region
of the c-Src that interacts with Csk (residues 504–523) and the
c-Src tail (residues 524–533) is highlighted in orange and
magenta, respectively. The side chain of the C-terminal resi-
due of c-Src (Leu 533) is shown as spheres, as is the Ca
atom of Tyr 527.
Csk participate in ion-pairing networks with gluta-
mate and aspartate residues in c-Src. c-Src resi-
dues 504–510 (from the aH/aI loop and helix I) en-
velop the C-terminal end of helix D of Csk (residues
274–281; Figures 3A and 3B). A helix-capping inter-
action occurs between theC-terminal end of helixD
of Csk and the 3-amino group of Lys 442 of c-Src
(Figure 3A). Helix I, comprising residues 508–519,
interacts with the C lobe of Csk so as to terminate
beneath the Csk active site (Figures 3B and 3C).
The N-terminal lobe of Csk is poorly ordered (Figure S4).
Constructs of Csk that lack the SH2 domain have substantially
reduced activity (Sondhi and Cole, 1999), and the kinase do-
main of Csk is, therefore, likely to be in an inactive conforma-
tion. However, the portion of Csk that interacts with c-Src is
well ordered and exhibits relatively low temperature factors
(the average Ca temperature factor is 94 A˚2 for residues of
Csk within 8 A˚ of c-Src, compared to the average temperature
factor of 129 A˚2 for all Ca atoms in Csk). This region adopts
a very similar conformation to that seen in the structure of
full-length Csk in an active conformation (Ogawa et al., 2002),
suggesting that full-length, active Csk forms a similar complex
with c-Src.
This expectation is confirmed by previousmutagenesis exper-
iments intended to investigate the determinants of the Csk:c-Src
interaction (Lee et al., 2003, 2006). These studies predicted the
importance of 6 residues (Arg 279, Arg 281, Arg 283 of Csk
and Glu 510, Tyr 511, Asp 518 of c-Src) for the interaction be-
tween full-length Csk and c-Src, and all of these residues indeed
make specific contacts in the Csk:c-Src interface. To further
confirm the crystallographic interface, we used surface plasmon
resonance to measure the effect of mutations in the Csk:c-Src
interface on the interaction between Csk and c-Src. Mutation
of any of the 5 arginine residues of Csk that contact c-Src inter-
feres with binding (Figure 3D). Likewise, mutation of Lys 442 or
Asp 518 of c-Src to alanine also prevents binding (Figure 3D)
and interferes with the phosphorylation of c-Src by Csk
(Figure 3E).126 Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc.
The c-Src Tail Is Disengaged from the Csk Active Site
but Is Positioned for Ready Entry
Kinase domains often bind substrates or inhibitory segments in
a docking groove that lies directly beneath the active site cleft
(Knighton et al., 1991). This docking groove is utilized by Csk to
bind to c-Src (Figure 4A). In our structure, as well as in previously
determined structures of c-Src, a kink occurs in helix I between
Tyr 519 and Phe 520, resulting in a separate helical turn (residues
520–524) that we refer to as helix I0 (Figure 4B). The kink positions
helix I0 so that it fits snugly into the docking groove of Csk.
The c-Src tail (Glu 524-Leu 533) that follows Helix I0 does not
engage the active site of Csk but extends away from Csk to
bind to the C lobe of c-Src (Figure 4B). The side chain of Tyr
527 packs against Phe 520, extending the perpendicular aroma-
tic:aromatic interactions that stabilize the kink between helix I
Figure 3. The Csk:c-Src Interface Probed
by Mutagenesis
(A)–(C) Details of the Csk:c-Src interface are
shown. The coloring scheme is the same as in
Figure 2. Residues important for the binding of
Csk to c-Src (see below) are indicated.
(D) The effects of mutations on the binding of Csk
to c-Src as measured by surface plasmon reso-
nance. On the left, the binding of mutants of CskFL
(25 mM) to c-SrcKD is shown. On the right, the
binding of WT CskFL (10 mM) to mutants of
c-SrcKD, immobilized on different surfaces, is
shown. Values are the means and standard devia-
tions from three series of injections.
(E) The effects of mutations in the Csk:c-Src inter-
face on the ability of Csk to phosphorylate c-Src,
measured by phosphorimaging, are shown.
Values are means and standard deviations from
three experiments.
and helix I0, and the phenol hydroxyl of
Tyr 527 forms a hydrogen bond to the
C-terminal carboxylate group of c-Src
(Figure 4B). This binding mode of the
c-Src tail is also seen in structures of the
isolated kinase domain of c-Src (Breiten-
lechner et al., 2005; Seeliger et al., 2007)
and in a structure of full-length active
c-Src (Cowan-Jacob et al., 2005).
That the c-Src tail can readily engage
the active site of Csk is shown by align-
ing the crystal structure of the insulin
receptor kinase (IRK), which contains
a substrate peptide bound at the active
site cleft (Hubbard, 1997) onto Csk in
our structure. The end of helix I0 of
c-Src then approaches to within 12 A˚
of the tyrosine residue of the IRK peptide
(11.5 A˚ between the Ca atoms of Ser
522 and the tyrosine residue; Figure 4A).
The 4 residues that link the end of Helix I0
to Tyr 527 are sufficient to span this
distance.
This fact is further confirmed by the lower-resolution
CskSH2KD:c-SrcKD structure, which contains twoCsk:c-Src com-
plexes in theasymmetric unit. Theconformations of thec-Srcand
Csk kinase domains in one of the complexes are similar to the
structure described above, but in the other complex, the c-Src
tail has disengaged from the c-Src C lobe and instead reaches
into the active site of Csk. In a difference electron density map
calculated using a model lacking the c-Src tail, the strongest
peak (at a contour level of 5sabove themeanvalueof theelectron
density) is located at the edge of the active site of Csk, just above
helix I0 (Figures 4C and S5). When contoured at a lower level
(2.0s), the electron density is consistent with the typical manner
in which peptide substrates bind to tyrosine kinases. Aligning
IRK onto Csk in this structure positions the IRK substrate peptide
within the electron density for the c-Src tail (Figure 4C).Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc. 127
The fact that the c-Src tail does not engage Csk in two of the
three crystallographically independent complexes reported here
could merely reflect the inactive nature of Csk in our crystals. Al-
ternatively, the Csk:c-Src interface seen in the structure may be
the dominant feature that determines the specific phosphoryla-
tion of c-Src by Csk, with the binding of the c-Src tail to the active
site of Csk being less important. This view is consistent with sev-
eral lines of evidence. The tails of the Src kinases are poorly con-
served even though Csk readily phosphorylates all Src family
members (Okada et al., 1991). Most substitutions in the tail of
c-Src have little impact on the kinetics of phosphorylation by
Csk (Wang et al., 2001), and a peptide comprising the sequence
of the c-Src tail is an extremely poor substrate for Csk, with
a value for kcat/Km that is four orders of magnitude below that
for c-Src protein (Sondhi et al., 1998).
The Anchoring of the Activation Loop of Csk
Is Disrupted by a Deletion
Thequestion remainsas towhyCskdoesnot readilyphosphorylate
other substrates, particularly peptide substrates. This led us to ask
Figure 4. The Conformation of the c-Src Tail
(A) (Left) The kinase domain of Csk from the CskKD:c-SrcKD
structure is depicted with only the C-terminal region of c-Src
(the aH/aI loop, helices I and I0, and the c-Src tail) shown.
The canonical binding site for peptide substrates is illustrated
by the substrate peptide from the structure of the insulin re-
ceptor kinase domain (IRK), shown in yellow (Hubbard,
1997). (Right) The structure of protein kinase A, in complex
with an inhibitory peptide that binds in the docking groove,
is depicted for comparison (Knighton et al., 1991).
(B) An enlarged view of the C-terminal portion of c-Src in the
CskKD:c-SrcKD structure. Perpendicular aromatic:aromatic
interactions that stabilize this conformation of the c-Src tail
are indicated with sticks and dots.
(C) In one of the complexes in the CskSH2KD:c-SrcKD structure,
the tail of c-Src binds in the active site of Csk. The substrate
peptide from the IRK ternary complex, aligned on the kinase
domain of Csk, is shown in yellow. A difference electron den-
sity map, contoured at two standard deviations over the mean
(2s), is shown in red. The map is calculated with coefficients
(jFoj  jFcj)eia(c), where jFoj are the observed structure factor
amplitudes and jFcj and a(c) are amplitudes and phases calcu-
lated from a model lacking the c-Src tail. See Figure S5 for
a more comprehensive view of the electron density map that
demonstrates the significance of the features shown here.
whether the binding site for peptide substrates, lo-
cated at the base of the active site cleft, is somehow
compromised in Csk. We analyzed tyrosine kinase
crystal structures in which the activation loops are
well ordered and in the active conformation (see Ex-
perimental Procedures). This diverse set contains six
receptor tyrosine kinases and six nonreceptor tyro-
sine kinases. Since tyrosine kinases bind substrates
in a distinct manner from serine/threonine kinases
(Huse et al., 1999), the conclusions of the analysis
that follows may not apply to Ser/Thr kinases.
In the active conformation, there are two distinct
regions of the activation loop that are anchored
onto the C lobe of the kinase domain; we refer to these as anchor
points 1 and 2 (Figure 5). The anchor points consist of two short
antiparallel b sheets formed by interactions between two sec-
tions of the activation loop and two loops in the C lobe of the
kinase (the catalytic loop and the aEF/aF loop for anchor points
1 and 2, respectively). Anchor point 1 (corresponding to residues
1155–1157 in IRK) begins 3 residues C-terminal to the catalyti-
cally important DFG motif and stabilizes the motif in the active
conformation (Nolen et al., 2004; Figure 5A). In addition to three
backbone hydrogen bonds that form the b sheet, anchor point 1
is further characterized by the insertion of the side chain of the
last residue of the anchor (Ile 1157 in IRK) into a pocket on the
surface of the C lobe. We refer to this residue as the hydrophobic
latch, because almost all tyrosine kinases have a large hydro-
phobic residue at this position. Anchor point 2 forms near the
C-terminal end of the activation loop (corresponding to residues
1163–1165 of IRK) and includes a tyrosine phosphorylation site
when present (Figure 5A). The backbone amide and carbonyl
groups of the tyrosine residue form two of the three hydrogen
bonds to the kinase C lobe.128 Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc.
The two anchor points are a structurally conserved feature of
the active conformation (Figure 5B). In all 12 structures, the dis-
tance between the Ca atom of the hydrophobic latch (the last
residue in anchor point 1) and the Ca atom of the activation
loop tyrosine (the first residue in anchor point 2) is between 6.2
and 7.2 A˚. In contrast, the segment of the activation loop that
connects anchor points 1 and 2 (referred to as the variable-
length loop in this paper), as well as the portion of the activation
loop C-terminal to anchor point 2, are relatively divergent in
structure (Figure 5B).
The proximity of anchor point 2 to the C-terminal end of the
activation loop, where peptide substrates bind, suggests that
anchor point 2 might influence peptide binding. In particular,
a conserved set of hydrophobic interactionsmight couple the en-
gagement of anchor point 2 to peptide binding (Figures 5C and
S6). These hydrophobic residues form a crevice on the surface
of the C lobe that comprises the binding site for the side chains
located one (P + 1) and three (P + 3) positions C-terminal to the
substrate tyrosine (Favelyukis et al., 2001; Hubbard, 1997; Levin-
son et al., 2006;Mol et al., 2003). Mutations at this binding site al-
ter substrate specificity (Konkol et al., 2000; Songyang et al.,
1995; Till et al., 1999; Yokoyama andMiller, 1999). Two of the hy-
drogenbonds formedbyanchorpoint2directly stabilizea residue
that is part of this network of hydrophobic interactions (Phe1186
in IRK; Figures 5CandS6). The backbone of this residue is further
linked to the peptide-binding site through the aEF/aF loop (Fig-
ures 5C and S6). Therefore, we envisage that the engagement
of anchor point 2 would stabilize these interactions and promote
peptide binding.
Figure 5. Activation Loop Anchoring in
Tyrosine Kinases
(A) The structure of the insulin receptor kinase do-
main (IRK) bound to a substrate peptide is shown.
The panel on the right shows an enlarged view
depicting the two anchor points and the loops to
which they form hydrogen bonds (shown as
dashed lines).
(B) The activation loops from 12 structures of
active tyrosine kinases (see Experimental Proce-
dures). The structures were aligned on the
catalytic loops, but only the activation loops are
shown.
(C) Hydrophobic interactions couple anchor point
2 to the peptide-binding site. The structure of
IRK is shown. Residues of the substrate peptide
that interact with the hydrophobic residues are
indicated.
A sequence alignment of the activation
loops of several tyrosine kinases demon-
strates that the anchoring mechanism
is disrupted in Csk (Figure 6A). The
variable-length loop that connects an-
chor points 1 and 2 is completely missing
in Csk and Chk. In order for the activation
loop of Csk to form both anchor points
simultaneously, the 6.5 A˚ distance
between the terminal Ca atoms of the
anchor points would have to be bridged by a single peptide
unit, which is clearly not possible without distortion of one or
both anchor points (the typical distance between Ca atoms of
adjacent amino acids in proteins is 3.8 A˚ [Creighton, 1993]).
The engagement of anchor points 1 and 2 is, therefore, expected
to be mutually exclusive in Csk. This is supported by the
observation that the activation loop is at least partly disordered
in all existing crystal structures of Csk. Since we expect anchor
point 2 to stabilize the peptide-binding site, the engagement
of anchor point 1, which is required to stabilize the DFG
motif in the active conformation, could interfere with peptide
binding.
Activation Loop Anchoring Affects the Activity
of Csk and c-Src toward Peptides
In an attempt to restore activation loop anchoring in Csk, we
made insertions in the activation loop (by introducing amino
acids derived from the variable-length loop of c-Src) that would
bridge the distance between anchor points 1 and 2. We also
mutated the hydrophobic latch of Csk from alanine to isoleucine
(the hydrophobic latch residue in c-Src). A kinetic assay demon-
strates that, when Csk is engineered to contain 2 or more
residues connecting the anchor points, the resulting proteins
possess a 3-fold greater activity than wild-type Csk toward pep-
tide substrates (Figure 6B). Insertion of a single amino acid, in
contrast, has no effect on activity (Figure 6B). This is consistent
with the architecture of the anchor points. Strikingly, all tyrosine
kinases other than Csk and Chk possess a minimum of two
amino acids between the anchor points.Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc. 129
In a previous study, replacement of the entire activation loop of
Csk with that of c-Src did not result in an increase in catalytic
activity (Lin et al., 2003). It is possible that this more extensive
replacement was not accommodated by the core of the kinase
domain, whereas the insertions we have made are located at
the edge of the kinase domain and are, therefore, tolerated.
To further test the importance of activation loop anchoring, we
deleted the variable-length loop in c-Src and mutated the hydro-
phobic latch residue to alanine. This c-Src mutant was well
folded, as indicated by an 1H-15N TROSY NMR spectrum
(Figure S7), but displays a 10-fold reduction in activity toward
peptides (Figure 6C). At least part of this decrease is due to
an elevated KM for the peptide substrate (Figure S7). These re-
sults suggest that activation loop anchoring is important for the
phosphorylation of peptide substrates and that the poor activity
of Csk toward peptides is at least partly a consequence of
disrupted anchoring.
Figure 6. Activation Loop Anchoring and
the Activity of Csk and c-Src toward Peptide
Substrates
(A) (Left) A schematic diagram is shown that high-
lights the characteristic features of the anchoring
mechanism. (Right) An alignment of the activation
loopsequencesofseveral tyrosinekinases isshown.
(B) The kinase activity of constructs ofCsk contain-
ing insertions in the activation loop is shown rela-
tive to WT Csk. The constructs are referred to as
CtoS-1 (for Csk to Src), CtoS-2, CtoS-3, and
CtoS-4dependingonwhether 1, 2, 3, or 4 residues,
respectively, were inserted. The mean value and
standard deviation of the relative rates from three
experiments are shown.
(C) The relative kinase activity of mutants of c-Src.
These constructs of the kinase domain either had
the hydrophobic latch mutated to alanine alone (IA)
or in combination with the deletion of the variable-
length loop (IA delta). The graphs show the mean
and standard deviation from two experiments.
Csk Can Discriminate between
Tail-Phosphorylated
and Unphosphorylated c-Src
The Src kinases are localized to mem-
branes constitutively through N-terminal
myristoylation (Brown and Cooper, 1996).
The restriction of protein molecules to
membrane surfaces can lead to increases
in effective concentrations of as much as
three orders of magnitude (Kholodenko
et al., 2000). While the affinity of Csk for
c-Src in solution is relatively weak (KD 30
mM), recruitment of Csk to the membrane,
which occurs when the Src kinases are ac-
tivated, could potentially result in saturation
of thec-SrcbindingsitesonCsk.Therefore,
we wondered whether Csk can distinguish
between active and inactive Src kinases.
We aligned the structure of inactive
assembled c-Src (Xu et al., 1997) onto
the C-terminal lobe of the kinase domain of c-Src (residues
350–520) in our structure. In this alignment, residues 523–526
of c-Src, corresponding to a portion of the phosphorylated c-Src
tail, clashwithCsk (Figure7A).A similar result is obtainedbyusing
the structure of the inactive form of the Src kinase Hck (Sicheri
et al., 1997). Hence, we expect that Csk cannot bind these inac-
tive forms of the Src kinases. Surface plasmon resonance exper-
iments demonstrate that phosphorylation of c-Src on Tyr 527 by
Csk prior to immobilization on the sensor surface prevents the
binding of Csk to c-Src (Figure 7B). Clearly, Csk can discriminate
between active c-Src molecules and those that have already
been tail-phosphorylated, preventing inactive c-Src from com-
peting with active c-Src for the binding site on Csk. We expect
that the samemechanism is atwork inChk to distinguish unphos-
phorylated c-Src fromphosphorylated c-Src (Chong et al., 2006).
A surprising feature of the alignment of inactive c-Src onto the
c-Src kinase domain in our structure is that the SH2/SH3 unit of130 Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc.
c-Src is brought into close proximity to the C lobe of Csk without
clashing with it. The SH3 and SH2 domains of c-Src may dock
onto the c-Src kinase domain to form the assembled structure
even in the absence of tail phosphorylation (Faraldo-Gomez
and Roux, 2007), so the Csk:c-Src interaction may have evolved
to permit binding of assembled but unphosphorylated c-Src
while discriminating against tail-phosphorylated c-Src.
The mechanism by which Csk discriminates between tail-
phosphorylated and unphosphorylated Src kinaseswould be cir-
cumvented when the Src kinases are activated by SH2 and SH3
ligands. With the SH2 domain displaced from the tail, Csk could
bind to c-Src even though the tail is phosphorylated. This could
potentially sequester Csk molecules and delay the downregula-
tion of Src kinase signaling.
Conclusion
There are two distinct factors that explain the unusual specificity
of Csk for the Src kinases: one that is intrinsic to Csk itself and
another that depends on features that are unique to the Src
kinases. The unusually short activation loop of Csk impedes
Figure 7. The Inactive Assembled State of
c-Src Is Incompatible with the Csk:c-Src
Complex
(A) The crystal structure of inactive assembled
c-Src (PDBcode2SRC) is aligned on theC-terminal
lobe of c-Src from our CskKD:c-SrcKD structure.
Clashes between the tail of inactive c-Src and
the C lobe of Csk are highlighted in black.
(B) Csk cannot bind tail-phosphorylated c-Src as
measured by surface plasmon resonance. A con-
struct of c-Src that contains the SH2, SH3, and
kinase domains (Src3D) was phosphorylated by
Csk on Tyr 527 (Src3D pY527) prior to immobiliza-
tion on the sensor surface. The binding of CskFL
(10 mM) to the surface was then measured. The
graphs show the mean and standard deviation of
two experiments.
the simultaneous engagement of two an-
chor points in the loop: one important for
catalysis and one for peptide substrate
binding. As a result, Csk does not readily
phosphorylate most proteins. The Src ki-
nases have evolved to circumvent the de-
stabilized peptide-binding site by binding
to Csk through a specific protein:protein
interface that orients the Src kinase tail
toward the active site of Csk.
Most tyrosine kinases are tightly regu-
lated, and the disruption of their inhibitory
mechanisms is frequently associated
with cancer. In contrast, Csk is constitu-
tively active under normal conditions.
Csk recognizes c-Src through a protein-
protein interaction that relies primarily
on electrostatic complementarity and hy-
drogen bonding. Such interactions have
high intrinsic specificity, allowing Csk to
select the Src kinases as unique targets. The inability of Csk to
bind and phosphorylate substrates other than the Src kinases
explains why a conventional regulatory mechanism like those
of other tyrosine kinases is not critical for Csk.
EXPERIMENTAL PROCEDURES
Protein Purification
The purification of the kinase domain of wild-type chicken c-Src (residues 251–
533, c-SrcKD) and a construct of c-Src that contains the SH2, SH3, and kinase
domains (residues 83–533, c-Src3D) from bacteria is described in detail else-
where (Seeliger et al., 2005). All constructs of Csk (CskFL, residues 1–450;
CskSH2KD, residues 68–450; and CskKD, residues 187–450) were expressed
as fusions with glutathione S-transferase (GST). The insertions in the activation
loop of Csk (CskCtoS-1, etc.) were made in the CskFL background by site-di-
rected mutagenesis, with the insertions derived from the c-Src variable-length
loop (encoding Glu-Asp-Asn-Glu). Csk constructs were expressed in E. coli
BL21 overnight at 18C. Cell pellets were resuspended in lysis buffer (50 mM
Tris-HCl, pH 8.0, 500 mM NaCl, 10% glycerol, 1 mM DTT) and lysed using
a cell disrupter. Cleared lysate was loaded on glutathione sepharose resin
(GE Healthcare). Protein was eluted with elution buffer (50 mM Bis-Tris,
pH 6.0, 10% glycerol, 10 mM reduced glutathione) and cleaved with PrecisionCell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc. 131
Protease (Amersham) to release GST. After digestion, protein was loaded onto
a HiTrap SP cation exchange column (GE Healthcare). The eluted sample was
buffer-exchanged by gel filtration chromatography (50 mM Tris-HCl, pH 8.0,
100 mM NaCl, 5% glycerol).
Crystallization of the Csk:c-Src Complex
Protein concentrations were determined by absorbance at 280 nm, and Csk
and c-Src proteins were combined in a 1:1 molar ratio prior to crystallization.
In the case of the CskKD:c-SrcKD crystals, the protein mixture was concen-
trated in the presence of a 2-fold molar excess of staurosporine (Sigma) prior
to crystallization. The nucleotide analog AMPPNP (Sigma) was added directly
to crystallization samples in the case of the CskSH2KD:c-SrcKD crystals.
The crystallization samples did not include reducing agents, which in retro-
spect, was critical to obtaining the crystals of the complex (see Results and
Discussion).
Crystals of the CskSH2KD:c-SrcKD complex grew in 0.2 M sodium malonate
(pH 7.0), 20% PEG 3350, while the CskKD:c-SrcKD crystals were obtained in
1.1 M sodium tartrate (pH 7.0). All crystals were cryoprotected in 25% glycerol
prior to being frozen in liquid nitrogen. X-ray diffraction data were collected at
the Advanced Light Source beamlines 8.2.1, 8.2.2, and 8.3.1.
Structure Determination and Refinement
Structures were solved by molecular replacement using Phaser (McCoy et al.,
2005), with models of the kinase domains of Csk and c-Src (1K9A chain A res-
idues 188–450 for Csk, 1YOM residues 260–520 for c-Src). Refinement was
performed with CNS (Brunger et al., 1998) and PHENIX (Adams et al., 2002)
and model building with Coot (Emsley and Cowtan, 2004). For the
CskSH2KD:c-SrcKD structure, rigid-body refinement was performed exclusively.
The SH2 domain of Csk could not be located and is not included in the model.
For the CskKD:c-SrcKD structure, individual atomic refinement was performed.
The model displays relatively low B factors for the c-Src kinase domain, the
Csk:c-Src interface, and the portion of Csk in the vicinity of the interface
(Figure S4). For the rest of the Cskmodel, there is a strong correlation between
the B factor of an individual atom and the distance of that atom from the Csk:
c-Src interface. While the electron density for the c-Src kinase domain was
strong, there was clear evidence of structural heterogeneity in the conforma-
tion of the activation loop of c-Src and the N-terminal lobe of Csk. We chose
to model only one conformation of these segments.
Surface Plasmon Resonance Experiments
Surface plasmon resonance experiments were performed with a BIACORE
2000 instrument. c-Src protein (c-SrcKD or c-Src3D) in 10 mM sodium acetate
(pH 5.0) was coupled to the chip surface in one of the flowcells using standard
amine coupling chemistry to a level of 2000 response units (RU), and a flowcell
that was activated and blocked without exposure to protein was used as a ref-
erence in all experiments. A flowcell to which the kinase domains of CamKII or
EGFR had been coupled was used to confirm that the binding of Csk to the
surface was specific for c-Src.
Csk constructs were diluted from concentrated stocks into HPS buffer
(10 mM HEPES [pH 7.5], 150 mM NaCl, 3 mM EDTA, 0.005% P20 surfactant
and 2 mM TCEP, a reducing agent that precludes disulfide bond formation be-
tween Csk and c-Src). Because of rapid binding kinetics, 60 s injections were
sufficient to reach equilibrium. The equilibrium response values obtained from
injections of Csk at different concentrations were fit to a ‘‘one site-specific
binding’’ model using GraphPad Prism version 5.0a (www.graphpad.com) to
derive the dissociation constant of the interaction.
Kinetic Assays
The phosphorylation of peptides by constructs of Csk and c-Src was mea-
sured using a coupled kinase assay (Seeliger et al., 2005) in reaction buffer
(100 mM Tris-HCl [pH 8.0], 10 mM MgCl2, 1 mM TCEP) with 1 mM ATP and
either 500 nM Csk or 16 nM c-Src. The peptide sequences used were the
optimal peptide substrate for c-Src (AEEEIYGEFEAKKKK) at 1 mM and the
optimal peptide substrate for Csk (KKKKEEIYFFF) at 250 mM. Peptides were
prepared by Dr. David King (University of California, Berkeley).
The phosphorylation of c-Src mutants by Csk was assayed by measuring
the incorporation of 32P phosphate into c-Src. To avoid complications due132 Cell 134, 124–134, July 11, 2008 ª2008 Elsevier Inc.to c-Src autophosphorylation, an inactive mutant form of c-Src was used
(Lys 295 Met). Reactions were performed in 60 mM Tris-HCl (pH 8.0), 30
mM NaCl, 50 mM unlabeled ATP, 0.5 mCi of g32P ATP, 2 mM MnCl2, 10 mM
DTT, 200 mg/ml BSA with 5 nM Csk, and 5 mM c-Src for 2 min at 30C. Radio-
activity was quantified using phosphorimaging with a typhoon imager (GE
Healthcare). Under these conditions, the phosphorylation of c-Src is linear
with time (Wang et al., 2001).
NMR Spectroscopy
15N-labeled c-SrcKD constructs were expressed in standard M9 media with
15N ammonium chloride as the sole nitrogen source and purified as described
above. Proteins were concentrated to 250 mM and exchanged into 100 mM
MES (pH 5.8), 200 mM NaCl, 1 mM DTT, 250 mM Dasatinib, and 10% D2O.
1H-15N Trosy NMR spectra (Pervushin et al., 1997) were recorded at 303 K
on a Bruker Avance 800MHz (18.8T) spectrometer, processed with NMRPipe,
and visualized in NMRdraw (Delaglio et al., 1995).
Structural Alignments of Active Kinases
The 12 tyrosine kinases (PDB codes in parentheses) used in the comparative
analysis are Lck (3LCK; Yamaguchi and Hendrickson, 1996), Fyn (2DQ7;
Kinoshita et al., 2006), c-Abl (2F4J; Young et al., 2006), IRK (1IR3; Hubbard,
1997), insulin-like growth factor 1 receptor (1K3A; Favelyukis et al., 2001), epi-
dermal growth factor receptor (2GS6; Zhang et al., 2006), c-Kit (1PKG; Mol
et al., 2003), fibroblast growth factor receptor (2PVF; Chen et al., 2007), Ret
(2IVV; Knowles et al., 2006), Syk (1XBA; Atwell et al., 2004), Janus kinase 3
(1YVJ; Boggon et al., 2005), and Fes (3BKB).
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The structures described here have been deposited in the Protein Data Bank
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